High risk of non-cancer mortality in bladder cancer patients: evidence from SEER-Medicaid

被引:3
|
作者
Wang, Shunde [1 ]
Ge, Chengguo [2 ]
机构
[1] ChenJiaqiao Hosp ShaPingba Dist Chongqing City, Dept Urol, Chongqing 401331, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Urol, 76 Linjiang Rd, Chongqing 400010, Peoples R China
关键词
Bladder cancer; Standardized mortality ratio; Non-cancer cause of death; Competing risk analysis; SEER; DEATH; CHEMOTHERAPY;
D O I
10.1007/s00432-023-04867-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeThe objective of this study was to investigate non-cancer causes of death and associated risk factors after bladder cancer (BC) diagnosis.MethodsEligible BC patients were obtained from the SEER database. SEER*Stat software 8.3.9.2 was used to calculate the standardized mortality ratios (SMRs). The proportions of different non-cancer cause of death were calculated and analyzed in different follow-up periods. Multivariate competing risk model was used to analyze the risk factors for death of BC and non-cancer diseases.ResultsIn total, 240,954 BC patients were included and 106,092 patients experienced death, with 37,205 (35.07%), 13,208 (12.45%) and 55,679 (52.48%) patients experienced BC, other cancer and non-cancer disease-related deaths, respectively. Overall SMR for BC patients who died from non-cancer diseases was 2.42 (95% CI [2.40-2.44]). Cardiovascular diseases were the most common non-cancer cause of death, followed by respiratory diseases, diabetes mellitus, and infectious diseases. Multivariate competing risk analysis identified the following high-risk factors for non-cancer mortality: age > 60 years, male, whites, in situ stage, pathological type of transitional cell carcinoma, not receiving treatment (including surgery, chemotherapy, or radiation), and widowed.ConclusionsCardiovascular diseases are the leading non-cancer cause of death in BC patients, followed by respiratory disease, diabetes mellitus and infectious diseases. Physicians should pay attention to the risk of death from these non-cancer diseases. Also, physicians should encourage patients to engage in more proactive self-surveillance and follow up.
引用
收藏
页码:10203 / 10215
页数:13
相关论文
共 50 条
  • [21] The Offspring of Atomic Bomb Survivors: Cancer and Non-Cancer Mortality and Cancer Incidence
    Suyama, Akihiko
    Izumi, Shizue
    Koyama, Kojiro
    Sakata, Ritsu
    Nishi, Nobuo
    Soda, Midori
    Grant, Eric J.
    Shimizu, Yukiko
    Furukawa, Kyoji
    Cullings, Harry M.
    Kasagi, Fumiyoshi
    Kodama, Kazunori
    RADIATION HEALTH RISK SCIENCES, 2009, : 57 - +
  • [22] The Evidence for Excess Risk of Cancer and Non-Cancer Disease at Low Doses and Dose Rates COMMENT
    Simon, S. L.
    Kendall, G. M.
    Bouffler, S. D.
    Little, M. P.
    RADIATION RESEARCH, 2022, 198 (06) : 615 - 624
  • [23] Health insurance continuity and survival among children, adolescents, and young adults with blood cancer: An analysis based on SEER-Medicaid data
    Ji, Xu
    Zhang, Elyse Xinyue
    Bai, Shasha
    Stock, Wendy
    Yabroff, Robin
    Mertens, Ann C.
    Castellino, Sharon M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Comparing the symptom experience of cancer patients and non-cancer patients
    Teresa L. Deshields
    Valentina Penalba
    Jingxa Liu
    James Avery
    Supportive Care in Cancer, 2017, 25 : 1103 - 1109
  • [25] Comparing the symptom experience of cancer patients and non-cancer patients
    Deshields, Teresa L.
    Penalba, Valentina
    Liu, Jingxa
    Avery, James
    SUPPORTIVE CARE IN CANCER, 2017, 25 (04) : 1103 - 1109
  • [26] Differences in the Psychotherapeutic Treatment of Cancer and Non-Cancer Patients
    Trill, Maria Die
    PSYCHO-ONCOLOGY, 2014, 23 : 63 - 63
  • [27] COVID-19 in Cancer and Non-cancer Patients
    Taghizadeh-Hesary, Farzad
    Porouhan, Pejman
    Soroosh, Davood
    PeyroShabany, Babak
    Shahidsales, Soodabeh
    Keykhosravi, Batol
    Rahimi, Faeze
    Houshyari, Mohammad
    Forouzanfar, Mohammad Mehdi
    Javadinia, Seyed Alireza
    INTERNATIONAL JOURNAL OF CANCER MANAGEMENT, 2021, 14 (04)
  • [28] Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database
    Shu, Timothy D. D.
    Schumacher, Fredrick R.
    Conroy, Britt
    Ponsky, Lee
    Mahran, Amr
    Bukavina, Laura
    Calaway, Adam
    Markt, Sarah C.
    CANCER CAUSES & CONTROL, 2023, 34 (06) : 521 - 531
  • [29] Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database
    Timothy D. Shu
    Fredrick R. Schumacher
    Britt Conroy
    Lee Ponsky
    Amr Mahran
    Laura Bukavina
    Adam Calaway
    Sarah C. Markt
    Cancer Causes & Control, 2023, 34 : 521 - 531
  • [30] RISK OF CANCER AND NON-CANCER DISEASES IN THE ATOMIC BOMB SURVIVORS
    Ozasa, Kotaro
    Shimizu, Yukiko
    Sakata, Ritsu
    Sugiyama, Hiromi
    Grant, Eric J.
    Soda, Midori
    Kasagi, Fumiyoshi
    Suyama, Akihiko
    RADIATION PROTECTION DOSIMETRY, 2011, 146 (1-3) : 272 - 275